RECENT POSTS
- Your First Move For Friday February 10th
- Home Builder Optimism Up, Industry Expert Says
- Chart Patterns Suggest Pullback at Hand
- UPDATE: Massive Trend Just Getting Underway in Financial Services: Finerman
- Terranova: Beware Nuance Play On Apple Spike
- Mortgage Settlement Could Buoy BofA Most: Traders
- Mark Mahaney Talks Akamai, Groupon, Yahoo ...
- iPad 3, iTV and iPhone 5 Should Drive Apple to $665: Money Pros
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
FULL SHOWSMissed an episode of Fast Money? Watch the latest show here.
HEDGE FUND TRADE OF THE WEEKWhich names are generating the most chatter across the hedge fund community this week?
CALL TO THE FLOOR | CEO EXTRACheck out our library of CEO interviews; conversations from TV as well as web exclusives.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTS
Download Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY SLIDESHOWS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up for our daily newsletter!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
Next Week's Big Mover – Healthcare
 |
Perhaps the most followed event of its kind the JP Morgan Health Care Conference kicks off Monday January 12th in San Francisco.
More than 300 companies, both public and private, come together to deliver presentations to more than 3,500 investors.
It’s a lot of information but here’s what the Fast Money traders and CNBC’s Mike Huckman recommend keeping an eye on.
Roche & Genentech
Huckman recommends keeping a eye on Roche and Genetech [DNA
Loading...
()
]. As you may know Genentech shares rose Friday after a published report said Swiss drugmaker Roche was preparing to sweeten its offer to buy the portion of the U.S. biotechnology giant it does not already own.
The Financial Times' Alphaville web site said Roche was preparing to offer about $95 per share, likely ahead of its release of its year-end financial report in early February.
If the deal happens, Roche could win billions of dollars in cancer drug revenue as well as strong R&D. And both are presenters at the conference.
Pete Najarian speculates the current offer might not be enough.
Other Names To Watch
According to Huckman this conference has really made its reputation on small cap biotechs. He thinks investors should look for bio-medical diamonds in the rough.
And the best way to play it is with the SPDR S&P Biotech [XBI
Loading...
()
], or iShares NASDAQ Biotechnology Index [IBB
Loading...
()
], explains Karen Finerman.
In addition, Huckman also thinks there could be news out of Genzyme [GENZ
Loading...
()
], Celgene [CELG
Loading...
()
] and Amgen [AMGN
Loading...
()
] three other presenters. They could re-affirm their guidance, or provide color on Q4 revenue which would, in turn, move their stocks, he says.
- Home Builder Optimism Up, Industry Expert Says
- Chart Patterns Suggest Pullback at Hand
- UPDATE: Massive Trend Just Getting Underway in Financial Services: Finerman
- Terranova: Beware Nuance Play On Apple Spike
- Top Fashion Stocks for 2012
- Pros Bullish On Visa, Even After It Hits a New High
- Semantics Suggest Higher Bid Ahead for Illumina: Finerman
- Premium Commanded by Whole Foods Ridiculous, or Surprisingly Modest?
- Caesar’s IPO Might Not Be a Good Bet, Pros Say
- Mega-Commodities Deal Puts Resource Stocks in Play
______________________________________________________
Got something to to say? Send us an e-mail at and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send your e-mail to .
Trader disclosure: On Jan 9, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Najarian Owns (CSCO), (DNA); Najarian Owns (XME) Calls, (NVLS) Calls, (NVDA) Calls; Najarian Owns (EEM) Long Call Spread ;Najarian Owns (ERTS) Long Call Spread; Karabell Owns (AAPL), (CL), (DRYS), (GOOG), (JPM), (NOK); Seymour Owns (AAPL), (BAC), (EEM), (F), (TSO); Seymour's Firm Owns (PBR); Finerman's Firm Owns (DSX), (MSFT), (DNA); Finerman's Firm Is Short (IYR), (IJR), (IWM), (MDY), (SPY), (USO), (ANF), (AEO), (BBT); Finerman's Firm Is Long (MSFT) Put Spreads
Data is a real-time snapshot *Data is delayed at least 15 minutes
